Annual Total Long Term Liabilities
$29.04 M
+$9.26 M+46.84%
December 31, 2023
Summary
- As of February 12, 2025, ATAI annual total long term liabilities is $29.04 million, with the most recent change of +$9.26 million (+46.84%) on December 31, 2023.
- During the last 3 years, ATAI annual total long term liabilities has risen by +$25.16 million (+648.12%).
- ATAI annual total long term liabilities is now at all-time high.
Performance
ATAI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$31.56 M
+$1.96 M+6.62%
September 30, 2024
Summary
- As of February 12, 2025, ATAI quarterly total long term liabilities is $31.56 million, with the most recent change of +$1.96 million (+6.62%) on September 30, 2024.
- Over the past year, ATAI quarterly long term liabilities has increased by +$11.55 million (+57.70%).
- ATAI quarterly long term liabilities is now at all-time high.
Performance
ATAI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ATAI Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +46.8% | +57.7% |
3 y3 years | +648.1% | +333.3% |
5 y5 years | +100.0% | +333.3% |
ATAI Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +299.4% | at high | +360.3% |
5 y | 5-year | at high | +3234.3% | at high | +713.0% |
alltime | all time | at high | -100.0% | at high | -100.0% |
Atai Life Sciences NV Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $31.56 M(+6.6%) |
Jun 2024 | - | $29.60 M(-4.1%) |
Mar 2024 | - | $30.85 M(+6.2%) |
Dec 2023 | $29.04 M(+46.8%) | $29.04 M(+45.1%) |
Sep 2023 | - | $20.01 M(-0.1%) |
Jun 2023 | - | $20.03 M(-0.5%) |
Mar 2023 | - | $20.12 M(+1.7%) |
Dec 2022 | $19.78 M(+172.0%) | $19.78 M(-4.0%) |
Sep 2022 | - | $20.60 M(+200.5%) |
Jun 2022 | - | $6.86 M(-5.9%) |
Mar 2022 | - | $7.28 M(+0.2%) |
Dec 2021 | $7.27 M(+87.3%) | $7.27 M(+20.6%) |
Sep 2021 | - | $6.03 M(-12.3%) |
Jun 2021 | - | $6.88 M(+10.9%) |
Mar 2021 | - | $6.21 M(+59.8%) |
Dec 2020 | $3.88 M(+345.7%) | $3.88 M(-41.1%) |
Sep 2020 | - | $6.59 M(-2.3%) |
Jun 2020 | - | $6.75 M(-11.2%) |
Mar 2020 | - | $7.60 M(-12.5%) |
Dec 2019 | $871.00 K(>+9900.0%) | - |
Dec 2019 | - | $8.68 M(+26.8%) |
Sep 2019 | - | $6.85 M(+4719.8%) |
Jun 2019 | - | $142.10 K(>+9900.0%) |
Mar 2019 | - | $0.00(0.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Sep 2018 | - | $5.69 M(-39.0%) |
Jun 2018 | - | $9.33 M(+2.3%) |
Mar 2018 | - | $9.12 M(+298.4%) |
Dec 2017 | $3.88 M(+9.6%) | - |
Sep 2017 | - | $2.29 M(-10.7%) |
Jun 2017 | - | $2.56 M(-27.5%) |
Mar 2017 | $3.53 M(+1116.6%) | $3.53 M(+1677.8%) |
Dec 2016 | - | $198.80 K(-19.4%) |
Sep 2016 | - | $246.80 K(-15.7%) |
Jun 2016 | - | $292.60 K(+0.7%) |
Mar 2016 | $290.50 K | $290.50 K(+27.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | - | $227.20 K(-12.2%) |
Sep 2015 | - | $258.70 K(-8.2%) |
Jun 2015 | - | $281.80 K(-0.8%) |
Mar 2015 | $284.10 K(-19.7%) | $284.10 K(+1.9%) |
Dec 2014 | - | $278.80 K(-6.2%) |
Sep 2014 | - | $297.10 K(-9.3%) |
Jun 2014 | - | $327.50 K(-7.4%) |
Mar 2014 | $353.80 K(-18.6%) | $353.80 K(-1.5%) |
Dec 2013 | - | $359.10 K(-5.1%) |
Sep 2013 | - | $378.50 K(-8.8%) |
Jun 2013 | - | $415.20 K(-4.5%) |
Mar 2013 | $434.90 K(-15.2%) | $434.90 K(+7.8%) |
Dec 2012 | - | $403.30 K(-7.7%) |
Sep 2012 | - | $436.90 K(-7.2%) |
Jun 2012 | - | $471.00 K(-8.2%) |
Mar 2012 | $513.00 K(-14.4%) | $513.00 K(-4.6%) |
Dec 2011 | - | $537.80 K(-2.3%) |
Sep 2011 | - | $550.50 K(-4.8%) |
Jun 2011 | - | $578.10 K(-3.5%) |
Mar 2011 | $599.30 K(-14.8%) | $599.30 K(-14.4%) |
Jun 2010 | - | $700.00 K(-0.4%) |
Mar 2010 | $703.00 K(-17.5%) | $703.00 K(-9.1%) |
Dec 2009 | - | $773.20 K(-2.5%) |
Sep 2009 | - | $792.80 K(+36.1%) |
Jun 2009 | - | $582.70 K(-31.6%) |
Mar 2009 | $852.00 K(-15.1%) | $852.00 K(-7.8%) |
Dec 2008 | - | $924.50 K(+0.5%) |
Sep 2008 | - | $919.50 K(-8.7%) |
Jun 2008 | - | $1.01 M(+0.3%) |
Mar 2008 | $1.00 M(-1.9%) | $1.00 M(-1.8%) |
Dec 2007 | - | $1.02 M(+1.4%) |
Sep 2007 | - | $1.01 M(-1.5%) |
Mar 2007 | $1.02 M(-4.3%) | $1.02 M |
Mar 2006 | $1.07 M(-15.4%) | - |
Mar 2004 | $1.26 M(-64.9%) | - |
Dec 2003 | $3.60 M | - |
FAQ
- What is Atai Life Sciences NV annual total long term liabilities?
- What is the all time high annual total long term liabilities for Atai Life Sciences NV?
- What is Atai Life Sciences NV annual total long term liabilities year-on-year change?
- What is Atai Life Sciences NV quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Atai Life Sciences NV?
- What is Atai Life Sciences NV quarterly long term liabilities year-on-year change?
What is Atai Life Sciences NV annual total long term liabilities?
The current annual total long term liabilities of ATAI is $29.04 M
What is the all time high annual total long term liabilities for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual total long term liabilities is $29.04 M
What is Atai Life Sciences NV annual total long term liabilities year-on-year change?
Over the past year, ATAI annual total long term liabilities has changed by +$9.26 M (+46.84%)
What is Atai Life Sciences NV quarterly total long term liabilities?
The current quarterly long term liabilities of ATAI is $31.56 M
What is the all time high quarterly long term liabilities for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly total long term liabilities is $31.56 M
What is Atai Life Sciences NV quarterly long term liabilities year-on-year change?
Over the past year, ATAI quarterly total long term liabilities has changed by +$11.55 M (+57.70%)